Josh's Shared Resources

Quantitative Speech Analysis Shows Promise as a Diagnostic Tool for Schizophrenia
Researchers of this study investigated whether quantitative speech characteristics could serve as reliable diagnostic indicators for schizophrenia....

Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University

Relapse Prevention in Schizophrenia: The Critical Role of Patients and Families
This comprehensive review examines the role of relapse prevention interventions in helping patients with schizophrenia and their families manage and...

Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University

Advancing Treatment for Treatment-Resistant Schizophrenia: Challenges and New Approaches
Treatment-resistant schizophrenia (TRS) impacts nearly one-third of patients who do not respond to dopamine-blocking antipsychotic medications....

Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University

Treatment-Resistant Schizophrenia: Challenges and Pathways Forward
Treatment-resistant schizophrenia (TRS) is defined by persistent positive symptoms despite trials with at least two different antipsychotics at adequate dose...

Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University

Study Finds No Clear Advantage of CBT Over Other Therapies for Schizophrenia
Authors of this Cochrane Review assessed the effectiveness of cognitive behavioral therapy (CBT) compared to other psychosocial therapies when used...

Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University

Researchers Investigate Relapse Risk and Predictors in Those With Schizophrenia Withdrawn From Treatment
This study quantified the risk and predictors of relapse among individuals with schizophrenia withdrawn from antipsychotic maintenance treatment....

Josh Hamilton,
DNP, APRN-BC, CTMH, CNE, CLNC, FAANP
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University
Chief Clinical Officer, The Hamilton Group Behavioral Health LLC; Clinical Professor and Chair, College of Nursing, Washington State University